➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
Mallinckrodt
Harvard Business School
AstraZeneca
Moodys

Last Updated: September 25, 2020

DrugPatentWatch Database Preview

Patent: 8,939,962

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,939,962
Title:System and method for urinary catheterization
Abstract: The embodiments herein provide an atraumatic urinary catheter. The atraumatic urinary catheter has a first tubule, a second tubule and a third tubule. The first tubule is provided with a first channel and a second channel. The first channel is wide and extended from a proximal end to a distal end of the first tubule and the first channel is open in both ends. The second tubule comprises a third channel, which is connected to a bladder cavity. The third tubule placed on the first tubule and the second tubule as a cover, to form a catheter\'s balloon. In order to avoid balloon explosion, the sterile water in the balloon is drained by the self-retaining mechanism of the catheter to prevent an irritation and tissue traumatization.
Inventor(s): Azar; Ramyar (Tehran, IR)
Assignee:
Application Number:14/101,634
Patent Claims:see list of patent claims

Details for Patent 8,939,962

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 001 2006-05-25   Start Trial 2039-09-22 search
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 1 2006-05-25   Start Trial 2039-09-22 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
AstraZeneca
Boehringer Ingelheim
Dow
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.